1 / 7

Tumor Ablation Market Strategies and Forecasts, 2020 to 2026

The global tumor ablation market is driven by the factors such as rising occurrence of different forms of cancer, technological advancements in the field of tumor ablation for cancer treatment, and rising awareness concerning the benefits of ablation procedures over conventional or traditional surgical procedures. Moreover, rising number of ablation centers, surgical centers, and hospitals are driving the growth of tumor ablation market globally.

priyankauke2013
Download Presentation

Tumor Ablation Market Strategies and Forecasts, 2020 to 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Tumor Ablation Market Market Set to Exceed USD 2.40 Billion by 2026 | CAGR 8.2%

  2. Tumor Ablation Market Size to Reach USD 2.40 Billion by 2026 “Tumor Ablation Market Size, Share, Trends & Industry Analysis By Type Of Technology (Radiofrequency (RF) Ablation, Microwave Ablation, Cryoablation, and Others); By Mode Of Treatment (Surgical Ablation, Laparoscopic Ablation, and Percutaneous Ablation); By Application (Liver Cancer, Lung Cancer, Kidney Cancer, Bone Metastasis, and Others); By Regions, Segment Forecast, 2020 – 2026” The global tumor ablation market is anticipated to reach USD 2.4 billion by 2026 according to a new study published by Polaris Market Research. Ablation is treatment for the destruction of liver tumors without removing them. These technique is used in patients with few small tumors and when surgery is not a worthy option due to reduced liver function or poor health condition. These treatment is sometimes used in patients waiting for a liver transplant. Generally, tumor ablation is a minimally invasive surgical method to treat solid cancers. Special probes are used to freeze or burn cancers without the surgery. Ultrasound (US), Computed Tomography (CT), or Magnetic Resonance Imaging (MRI) are used to guide and position the needle probe into the tumor. The most common cancers treated by this method are lung cancer, liver cancer and kidney (renal) cancer. Other cancers can also be treated if the tumor cell are accessible to reach and of appropriate size The global tumor ablation market is driven by the factors such as rising occurrence of different forms of cancer, technological advancements in the field of tumor ablation for cancer treatment, and rising awareness concerning the benefits of ablation procedures over conventional or traditional surgical procedures. Moreover, rising number of ablation centers, surgical centers, and hospitals are driving the growth of tumor ablation market globally. Additionally, the continual developments in ablation expertise, leading to the increased development of new and pioneering products that are the efficient, safe, and minimally invasive are also advancing towards significant growth of the global tumor ablation market. Browse Detailed Research Report On Tumor Ablation Market: https://www.polarismarketresearch.com/industry-analysis/global-tumor-ablation-market With the increasing geriatric population, the demand for minimally invasive surgeries (MIS) is increasing globally. Through minimally intrusive surgeries, the patients result in faster recovery in comparison to conventional invasive procedures. Therefore, the demand for minimally invasive procedures such as radiofrequency ablation and cryoablation is increasing and thereby augmenting the global market growth. The global tumor ablation market is segmented on the basis of type of technology, mode of treatment, and application. On the basis of type of technology, the global tumor ablation market is segmented - 2 -

  3. Tumor Ablation Market Size to Reach USD 2.40 Billion by 2026 into Radiofrequency (RF) ablation, Microwave ablation, Cryoablation, and others. The radiofrequency ablation is estimated to dominate the global tumor ablation market owing to its design of treating target tissues without causing damage to the surrounding healthy cells. However, microwave ablation technology is expected to grow at the rapid test rate in the upcoming years, due to increasing adoption of microwave tumor ablation among healthcare specialists. On the basis of the type of technology, the global tumor ablation market is further categorized into surgical ablation, laparoscopic ablation, and percutaneous ablation. Moreover, on the basis of application the market is segmented into liver cancer, lung cancer, kidney cancer, bone metastasis, and others. Lung cancer is anticipated to grow with the fastest rate in the forecast period due to growing prevalence of lung cancer cases and increasing private as well as government investment to develop new lung cancer ablation products. Some of the key players operating in global tumor ablation market are EDAP TMS S.A., St. Jude Medical Inc., BVM Medical Ltd., SonaCare Medical LLC, AngioDynamics Inc., Boston Scientific Corp., BTG International Ltd., Integra LifeSciences Holdings Corp., and Medtronic plc. among others. Request for sample: https://www.polarismarketresearch.com/industry-analysis/global-tumor- ablation-market/request-for-sample Table of Contents 1. Overview and Scope 1.1. Research goal & scope - 3 -

  4. Tumor Ablation Market Size to Reach USD 2.40 Billion by 2026 1.2. Research assumptions 1.3. Research Methodology 1.3.1. Primary data sources 1.3.2. Secondary data sources 1.4. Key take-aways 1.5. Stakeholders 2. Executive Summary 2.1. Market Definition 2.2. Market Segmentation 3. Tumor Ablation Market Insights 3.1. Tumor ablation– Industry snapshot 3.2. Tumor ablation -Ecosystem analysis 3.3. Tumor ablation market dynamics 3.3.1. Tumor ablation– Market Forces 3.3.1.1. Tumor ablation Market driver analysis 3.3.1.2. Tumor ablation Market restraint/challenges analysis 3.3.1.3. Tumor ablation Market opportunity analysis 3.3.2. Industry analysis - Porter's five force 3.3.2.1. Bargaining power of supplier 3.3.2.2. Bargaining power of buyer 3.3.2.3. Threat of substitute 3.3.2.4. Threat of new entrant 3.3.2.5. Degree of competition 3.3.3. Tumor ablation market PEST analysis, 2019 3.3.4. Value Chain Analysis 3.3.5. Tumor ablation Industry trends 3.3.6. Prevalence of tumor ablation 4. Tumor ablation Market Size and Forecast by type of technology 4.1. Key findings 4.2. Radiofrequency (RF) ablation 4.2.1. Global market estimates and forecasts, 2020-2026 4.3. Microwave ablation 4.3.1. Global market estimates and forecasts, 2020-2026 4.4. Cryoablation 4.4.1. Global market estimates and forecasts, 2020-2026 4.5. Others 4.5.1. Global market estimates and forecasts, 2020-2026 5. Tumor ablation Market Size and Forecast by Mode of treatment 5.1. Key findings 5.2. Surgical ablation 5.2.1. Global market estimates and forecasts, 2020-2026 5.3. Laparoscopic ablation 5.3.1. Global market estimates and forecasts, 2020-2026 5.4. Percutaneous ablation 5.4.1. Global market estimates and forecasts, 2020-2026 6. Tumor ablation Market Size and Forecast by Application 6.1. Key findings 6.2. Liver cancer 6.2.1. Global market estimates and forecasts, 2020-2026 6.3. Lung cancer 6.3.1. Global market estimates and forecasts, 2020-2026 6.4. Kidney cancer - 4 -

  5. Tumor Ablation Market Size to Reach USD 2.40 Billion by 2026 6.4.1. Global market estimates and forecasts, 2020-2026 6.5. Bone metastasis 6.5.1. Global market estimates and forecasts, 2020-2026 6.6. Others 6.6.1. Global market estimates and forecasts, 2020-2026 7. Tumor ablation Market Size and Forecast by Regions 7.1. Key findings 7.2. North America 7.2.1. Tumor ablation Market by Type of Technology (USD Million), 2020-2026 7.2.2. Tumor ablation Market by Mode of treatment (USD Million), 2020-2026 7.2.3. Tumor ablation Market by application (USD Million), 2020-2026 7.2.4. U.S. 7.2.4.1. Tumor ablation Market by Type of Technology (USD Million), 2020-2026 7.2.4.2. Tumor ablation Market by Mode of treatment (USD Million), 2020-2026 7.2.4.3. Tumor ablation Market by application (USD Million), 2020-2026 7.2.5. Canada 7.2.5.1. Tumor ablation Market by Type of Technology (USD Million), 2020-2026 7.2.5.2. Tumor ablation Market by Mode of treatment (USD Million), 2020-2026 7.2.5.3. Tumor ablation Market by application (USD Million), 2020-2026 7.3. Europe 7.3.1. Tumor ablation Market by Type of Technology (USD Million), 2020-2026 7.3.2. Tumor ablation Market by Mode of treatment (USD Million), 2020-2026 7.3.3. Tumor ablation Market by application (USD Million), 2020-2026 7.3.4. Germany 7.3.4.1. Tumor ablation Market by Type of Technology (USD Million), 2020-2026 7.3.4.2. Tumor ablation Market by Mode of treatment (USD Million), 2020-2026 7.3.4.3. Tumor ablation Market by application (USD Million), 2020-2026 7.3.5. UK 7.3.5.1. Tumor ablation Market by Type of Technology (USD Million), 2020-2026 7.3.5.2. Tumor ablation Market by Mode of treatment (USD Million), 2020-2026 7.3.5.3. Tumor ablation Market by application (USD Million), 2020-2026 7.4. Asia Pacific 7.4.1. Tumor ablation Market by Type of Technology (USD Million), 2020-2026 7.4.2. Tumor ablation Market by Mode of treatment (USD Million), 2020-2026 7.4.3. Tumor ablation Market by application (USD Million), 2020-2026 7.4.4. China 7.4.4.1. Tumor ablation Market by Type of Technology (USD Million), 2020-2026 7.4.4.2. Tumor ablation Market by Mode of treatment (USD Million), 2020-2026 7.4.4.3. Tumor ablation Market by application (USD Million), 2020-2026 7.4.5. India 7.4.5.1. Tumor ablation Market by Type of Technology (USD Million), 2020-2026 7.4.5.2. Tumor ablation Market by Mode of treatment (USD Million), 2020-2026 7.4.5.3. Tumor ablation Market by application (USD Million), 2020-2026 7.4.6. Japan 7.4.6.1. Tumor ablation Market by Type of Technology (USD Million), 2020-2026 7.4.6.2. Tumor ablation Market by Mode of treatment (USD Million), 2020-2026 7.4.6.3. Tumor ablation Market by application (USD Million), 2020-2026 7.5. Latin America 7.5.1. Tumor ablation Market by Type of Technology (USD Million), 2020-2026 7.5.2. Tumor ablation Market by Mode of treatment (USD Million), 2020-2026 7.5.3. Tumor ablation Market by application (USD Million), 2020-2026 7.5.4. Brazil - 5 -

  6. Tumor Ablation Market Size to Reach USD 2.40 Billion by 2026 7.5.4.1. 7.5.4.2. 7.5.4.3. 7.5.5. Mexico 7.5.5.1. 7.5.5.2. 7.5.5.3. 7.6. Middle East & Africa 7.6.1. Tumor ablation Market by Type of Technology (USD Million), 2020-2026 7.6.2. Tumor ablation Market by Mode of treatment (USD Million), 2020-2026 7.6.3. Tumor ablation Market by application (USD Million), 2020-2026 8. Company Profiles 8.1. EDAP TMS S.A. 8.1.1. Overview 8.1.2. Financials 8.1.3. Product Type Benchmarking 8.1.4. Recent Developments 8.2. Jude Medical Inc. 8.2.1. Overview 8.2.2. Financials 8.2.3. Product Type Benchmarking 8.2.4. Recent Developments 8.3. BVM Medical Ltd. 8.3.1. Overview 8.3.2. Financials 8.3.3. Product Type Benchmarking 8.3.4. Recent Developments 8.4. SonaCare Medical LLC 8.4.1. Overview 8.4.2. Financials 8.4.3. Product Type Benchmarking 8.4.4. Recent Developments 8.5. AngioDynamics Inc. 8.5.1. Overview 8.5.2. Financials 8.5.3. Product Type Benchmarking 8.5.4. Recent Developments 8.6. Boston Scientific Corp. 8.6.1. Overview 8.6.2. Financials 8.6.3. Product Type Benchmarking 8.6.4. Recent Developments 8.7. Pacific Biosciences of California, Inc 8.7.1. Overview 8.7.2. Financials 8.7.3. Product Type Benchmarking 8.7.4. Recent Developments 8.8. BTG International Ltd. 8.8.1. Overview 8.8.2. Financials 8.8.3. Product Type Benchmarking 8.8.4. Recent Developments Tumor ablation Market by Type of Technology (USD Million), 2020-2026 Tumor ablation Market by Mode of treatment (USD Million), 2020-2026 Tumor ablation Market by application (USD Million), 2020-2026 Tumor ablation Market by Type of Technology (USD Million), 2020-2026 Tumor ablation Market by Mode of treatment (USD Million), 2020-2026 Tumor ablation Market by application (USD Million), 2020-2026 - 6 -

  7. Tumor Ablation Market Size to Reach USD 2.40 Billion by 2026 8.9. Integra Life Sciences Holdings Corp. 8.9.1. Overview 8.9.2. Financials 8.9.3. Product Type Benchmarking 8.10. Medtronic plc. 8.10.1. Overview 8.10.2. Financials 8.10.3. Product Type Benchmarking 8.10.4. Recent Developments Access Press Release on Tumor Ablation Market: https://www.polarismarketresearch.com/press-releases/tumor-ablation-market About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com - 7 -

More Related